Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
1.19%177.840.4%$173.61m
VRXValeant Pharmaceuticals International, Inc.
1.08%9.3913.2%$150.67m
PRGOPerrigo Co. Plc
1.44%74.076.1%$144.79m
ALRAlere Inc.
-0.18%49.102.7%$133.79m
JAZZJazz Pharmaceuticals Plc
2.70%162.012.3%$91.66m
UTHRUnited Therapeutics Corporation
0.43%120.5012.9%$89.69m
ENDPEndo International Plc
1.17%11.2810.8%$74.66m
MDCOMedicines Company
-2.35%48.5822.5%$74.51m
MNKMallinckrodt Plc
0.42%46.3917.0%$70.93m
HZNPHorizon Pharma plc
0.91%15.497.6%$42.49m
ICPTIntercept Pharmaceuticals, Inc.
-0.19%113.2322.3%$35.93m
PRXLPAREXEL International Corporation
1.65%63.387.9%$33.46m
ICLRICON Plc
8.25%83.173.9%$32.92m
PCRXPacira Pharmaceuticals, Inc.
1.59%48.0512.2%$30.37m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.70%118.438.2%$28.78m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.